XML 39 R28.htm IDEA: XBRL DOCUMENT
v3.21.1

Revenue (Tables) | 6 Months Ended
--- | ---
Mar. 27, 2021
Revenue from Contract with Customer [Abstract] |
Disaggregation of Revenue | The following tables provide revenue from contracts with customers by business and geographic region on a disaggregated basis:
|  | Three Months Ended March 27, 2021 |  | Three Months Ended March 28, 2020
Business (in millions) | United States | International | Total |  | United States | International | Total
Diagnostics: |  |  |  |  |  |  |
| Cytology & Perinatal | $ | 76.8 |  | $ | 40.4 |  | $ | 117.2 |  |  | $ | 73.2 |  | $ | 40.2 |  | $ | 113.4 |
| Molecular Diagnostics | 616.4 |  | 318.9 |  | 935.3 |  |  | 149.8 |  | 40.8 |  | 190.6 |
| Blood Screening | 12.0 |  | — |  | 12.0 |  |  | 15.2 |  | — |  | 15.2 |
Total | $ | 705.2 |  | $ | 359.3 |  | $ | 1,064.5 |  |  | $ | 238.2 |  | $ | 81.0 |  | $ | 319.2 |
Breast Health: |  |  |  |  |  |  |
| Breast Imaging | $ | 198.1 |  | $ | 71.8 |  | $ | 269.9 |  |  | $ | 186.0 |  | $ | 64.2 |  | $ | 250.2 |
| Interventional Breast Solutions | 54.9 |  | 11.5 |  | 66.4 |  |  | 48.4 |  | 9.2 |  | 57.6 |
Total | $ | 253.0 |  | $ | 83.3 |  | $ | 336.3 |  |  | $ | 234.4 |  | $ | 73.4 |  | $ | 307.8 |
GYN Surgical | $ | 91.7 |  | $ | 22.5 |  | $ | 114.2 |  |  | $ | 86.7 |  | $ | 18.7 |  | $ | 105.4 |
Skeletal Health | $ | 14.1 |  | $ | 8.5 |  | $ | 22.6 |  |  | $ | 15.6 |  | $ | 8.1 |  | $ | 23.7 |
|  | $ | 1,064.0 |  | $ | 473.6 |  | $ | 1,537.6 |  |  | $ | 574.9 |  | $ | 181.2 |  | $ | 756.1 |
|  | Six Months Ended March 27, 2021 |  | Six Months Ended March 28, 2020
Business (in millions) | United States | International | Total |  | United States | International | Total
Diagnostics: |  |  |  |  |  |  |
| Cytology & Perinatal | $ | 156.9 |  | $ | 85.1 |  | $ | 242.0 |  |  | $ | 150.7 |  | $ | 83.7 |  | $ | 234.4 |
| Molecular Diagnostics | 1,291.6 |  | 639.0 |  | 1,930.6 |  |  | 291.9 |  | 77.2 |  | 369.1 |
| Blood Screening | 20.1 |  | — |  | 20.1 |  |  | 27.2 |  | — |  | 27.2 |
Total | $ | 1,468.6 |  | $ | 724.1 |  | $ | 2,192.7 |  |  | $ | 469.8 |  | $ | 160.9 |  | $ | 630.7 |
Breast Health: |  |  |  |  |  |  |
| Breast Imaging | $ | 401.1 |  | $ | 136.5 |  | $ | 537.6 |  |  | $ | 395.4 |  | $ | 129.6 |  | $ | 525.0 |
| Interventional Breast Solutions | 110.1 |  | 21.4 |  | 131.5 |  |  | 95.5 |  | 18.4 |  | 113.9 |
Total | $ | 511.2 |  | $ | 157.9 |  | $ | 669.1 |  |  | $ | 490.9 |  | $ | 148.0 |  | $ | 638.9 |
GYN Surgical | $ | 192.8 |  | $ | 45.4 |  | $ | 238.2 |  |  | $ | 185.5 |  | $ | 39.0 |  | $ | 224.5 |
Medical Aesthetics | $ | — |  | $ | — |  | $ | — |  |  | $ | 30.9 |  | $ | 34.4 |  | $ | 65.3 |
Skeletal Health | $ | 29.1 |  | $ | 18.3 |  | $ | 47.4 |  |  | $ | 30.5 |  | $ | 16.7 |  | $ | 47.2 |
|  | $ | 2,201.7 |  | $ | 945.7 |  | $ | 3,147.4 |  |  | $ | 1,207.6 |  | $ | 399.0 |  | $ | 1,606.6 |
|  | Three Months Ended |  | Six Months Ended
Geographic Regions (in millions) |  | March 27, 2021 | March 28, 2020 |  | March 27, 2021 | March 28, 2020
United States |  | $ | 1,064.0 |  | $ | 574.9 |  |  | $ | 2,201.7 |  | $ | 1,207.6 |
Europe |  | 336.8 |  | 111.8 |  |  | 675.0 |  | 221.2 |
Asia-Pacific |  | 90.1 |  | 41.7 |  |  | 178.5 |  | 111.8 |
Rest of World |  | 46.7 |  | 27.7 |  |  | 92.2 |  | 66.0 |
|  | $ | 1,537.6 |  | $ | 756.1 |  |  | $ | 3,147.4 |  | $ | 1,606.6 |
The following table provides revenue recognized by source:
|  | Three Months Ended |  | Six Months Ended
Revenue by type (in millions) |  | March 27, 2021 | March 28, 2020 |  | March 27, 2021 | March 28, 2020
Disposables |  | $ | 1,178.1 |  | $ | 457.0 |  |  | $ | 2,441.5 |  | $ | 923.4 |
Capital equipment, components and software |  | 200.7 |  | 166.6 |  |  | 392.7 |  | 399.5 |
Service |  | 141.8 |  | 127.2 |  |  | 278.9 |  | 272.2 |
Other |  | 17.0 |  | 5.3 |  |  | 34.3 |  | 11.5 |
|  | $ | 1,537.6 |  | $ | 756.1 |  |  | $ | 3,147.4 |  | $ | 1,606.6 |

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration